BCTG Acquisition Corp. (BCTG) Prices Upsized $145M IPO
BCTG Acquisition Corp. announced the pricing of its upsized $145 million IPO this morning and its shares are expected to begin trading today, Thursday, September 3rd, under the symbol Nasdaq: BCTG.
The new SPAC intends to focus on companies in the biotechnology space and will be led by Aaron I. Davis as Chairman and CEO, with Christopher Fuglesang, Ph.D., J.D. serving as President and Director. Michael Beauchamp will also serve as CFO and Treasurer while Andrew Ellis, M.D., J.D. serves as COO and Secretary.
Total SPAC deal count for 2020 year-to-date is now 84 with $33.9 billion in gross proceeds raised. The offering is anticipated to close on Tuesday, September 8, 2020.
SVB Leerink is serving as the sole book runner for the offering. Loeb & Loeb LLP and Kirkland & Ellis, were Issuer’s Counsel and Underwriter’s Counsel, respectively. WithumSmith+Brown, PC, acted as auditor. Continental Stock Transfer & Trust Company is acting as trustee.